At present, three types of MDS defined by genetic abnormalities are recognized: MDS with low blasts and isolated 5q deletion (MDS-5q); MDS with low blasts and SF3B1 mutation (SF3B1-MDS); and MDS with biallelic TP53 inactivation (MDS-biTP53). Here, TP53 is linked to myelodysplastic syndrome.